Clinical Trial

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Study acronym: mina
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To compare the outcome of topical minoxidil 5% spray versus oral minoxidil 2.5 mg tablet for the treatment of androgenetic alopecia in males and females. Outcomes include efficacy of the treatment, measured by reduction in hair shedding, improvement in hair density and new hair growth as assessed by physican and patient assessment as well as safety, defined as incidence and severity of adverse events over a treatment period of 6 months
Trial Details
NCT Number NCT07273799
Lead Sponsor Sheikh Zayed Federal Postgraduate Medical Institute
Conditions Androgenic Alopecia
Enrollment 200 participants
Start Date 2025-12-20
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-10